Emerging Infections Program
The Emerging Infections Program (EIP) is part of a national effort to provide population-based communicable disease data for surveillance of disease patterns, evaluation of vaccine programs, and to identify populations at risk for severe infection and those in need of screening and preventive care. EIP projects include studies of risk factors for influenza disease requiring hospital admission, methicillin-resistant Staphylococcus aureus (MRSA), and Clostridium difficile in healthcare and community settings.
- Clostridium difficile Surveillance
- Influenza Hospitalization Surveillance
- Methicillin-resistant Staphylococcus aureus (MRSA)
- HPV Vaccine Impact
- Drug-Resistant Bacteria (MuGSI)
Contact the Communicable Disease Surveillance and Prevention program at (585) 224-3075 or by email at Center for Community Health.